DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Five Prime Therapeutics, Inc. (FPRX)
« Back to company indexFPRX Chatter Timeline
Stock Ticker for FPRX
Most Active Tweeters for FPRX
No tweets foundRecent Tweets for FPRX
 |
@EnterpriseLeade Five Prime Therapeutics $FPRX Downgraded to Strong Sell at ValuEngine https://t.co/8s5otQl8UP August 21st 2018, 11:08pm |
 |
@InsiderAlertsIA $FPRX: New Insider Filing on President & CEO ARON MARC KNICKERBOCKER: https://t.co/sFZ6ox8zYg August 21st 2018, 5:08pm |
 |
@LargeVoidBot Daily Reversal (13:26): $FPRX Last: 13.39; pHigh: 13.38; rVol: 1.034; pClose: 13.30; LOD: 12.9100; Perf: 0.7% August 21st 2018, 5:08pm |
 |
@StockTexts $FPRX Five Prime Therapeutics, Inc. SEC Filing: Form 4 https://t.co/Ikw1J5uDvU August 21st 2018, 4:08pm |
 |
@ZolmaxNews Five Prime Therapeutics $FPRX Price Target Cut to $44.00 by Analysts at Citigroup https://t.co/abdPrNUX3c August 21st 2018, 9:08am |
 |
@dakotafinancial Five Prime Therapeutics $FPRX Reaches New 12-Month Low Following Analyst Downgrade https://t.co/b2xkp2ot0G August 21st 2018, 5:08am |
 |
@TheMarketsDaily Five Prime Therapeutics $FPRX Hits New 12-Month Low on Analyst Downgrade https://t.co/2CW6iJZaEa August 20th 2018, 5:08pm |
 |
@AmericanBanking Five Prime Therapeutics $FPRX Given New $44.00 Price Target at Citigroup https://t.co/XZ9r1EtWBP #stocks August 20th 2018, 3:08pm |
 |
@Emylers FPRX Stock 13.25 Five Prime Thera $FPRX Hit 288,685 52 week lows as of +4.50%. Currently trading at 13.25 +0.0 https://t.co/0suAVNwDY8 August 20th 2018, 2:08pm |
|
@dakotafinancial Citigroup Trims Five Prime Therapeutics $FPRX Target Price to $44.00 https://t.co/jP2zo9h5XI August 20th 2018, 2:08pm |
 |
@macondailynews Citigroup Trims Five Prime Therapeutics $FPRX Target Price to $44.00 https://t.co/SN2YzOfNI3 August 20th 2018, 2:08pm |
 |
@tgtxdough Citi $FPRX conservative,stripped out PVNS study from pipeline, which results in a ~$7/sh cut to our DCF.cabiralizum… https://t.co/fhZ3kwZbnR August 20th 2018, 1:08pm |
 |
@The_CasualSmart Trillium Asset Management Has Lifted By $343,740 Its Five Prime Therapeutics $FPRX Holding; 10 Analysts Bullish Hal… https://t.co/sf1GOINN4P August 20th 2018, 12:08pm |
 |
@bibeypost_stock Five Prime Therapeutics $FPRX "Buy" Rating Reiterated Today By Citigroup; The PT Given is $44 - https://t.co/84LyEOCxeY August 20th 2018, 11:08am |
 |
@reurope_stock Today Citigroup Reconfirms a "Buy" Rating on Five Prime Therapeutics $FPRX and a $44 Target Price https://t.co/RhA8MKSgBa August 20th 2018, 11:08am |
 |
@mmahotstuff1 Citigroup Reconfirms Five Prime Therapeutics $FPRX As a Buy; They Now Have a TP Of $44 - https://t.co/5zWQVZlVO5 August 20th 2018, 11:08am |
|
@The_CasualSmart Citigroup Has Just Reaffirmed $44 Target Price Per Share on Five Prime Therapeutics $FPRX stock, While They’ve Also… https://t.co/PhABpus4F1 August 20th 2018, 11:08am |
 |
@whatsonthorold2 Analysts at Citigroup Reiterated their Past ‘Buy’ rating on Shares Five Prime Therapeutics $FPRX, Set a $44 Price T… https://t.co/aymo2Ix7nP August 20th 2018, 11:08am |
 |
@west_moreland Key Analysts at Citigroup Kept their ‘"Buy"’ rating for Five Prime Therapeutics $FPRX Shares Today. Their Target Pr… https://t.co/f8kGpbJQse August 20th 2018, 11:08am |
|
@The_CasualSmart Today Citigroup Keeps a Buy Rating on Five Prime Therapeutics $FPRX and a $44 Target Price https://t.co/8vK0R7IYrx August 20th 2018, 11:08am |
 |
@Fanob_stock Breaking: Five Prime Therapeutics $FPRX Buy Rating Reaffirmed at Citigroup Today; The Target Given is $44 https://t.co/EqwEp8zyL9 August 20th 2018, 11:08am |
 |
@Luigimoro69 @stb8444 $FPRX Have been investing long in biotechs? this was over 40 last October and will go there again. Shortse… https://t.co/UfHRdqWSRF August 20th 2018, 10:08am |
 |
@stb8444 $fprx someone is getting steamrolled here $12 August 20th 2018, 9:08am |
 |
@odibro $FPRX maintained with a buy at CITI. PT $44 August 20th 2018, 7:08am |
 |
@laang15 Binance registration is currently open Register link and BONUS ? https://t.co/mTmCbzBn3W ? 08/20 04:03 $FPRX $GDO… https://t.co/mltc1ZVXLy August 20th 2018, 4:08am |
|
@Luigimoro69 @BenjiMax2 @DrSManian $FPRX about 250m cash by end of the year unbelievable cheap IMO and a big pipeline and trials… https://t.co/BtUAza2Xdi August 19th 2018, 5:08pm |
|
@sunrgu @DrSManian Standout $FPRX and may be $SYBX August 19th 2018, 3:08pm |
 |
@MareaInformativ Wedbush Boosts Five Prime Therapeutics $FPRX Price Target to $19.00 https://t.co/77yEfv7OIb August 19th 2018, 11:08am |
 |
@beyond_ninety Kdi Capital Partners Trimmed Lawson Prods $LAWS Holding; Five Prime Therapeutics, Inc. $FPRX Had 3 Bulls https://t.co/lm0jwcsZy2 August 19th 2018, 9:08am |
|
@ZolmaxNews Five Prime Therapeutics $FPRX Downgraded by BidaskClub https://t.co/i0UBpCq0kU August 19th 2018, 4:08am |
 |
@TickerReport -$1.16 EPS Expected for Five Prime Therapeutics Inc $FPRX This Quarter https://t.co/DAPjIkf6F6 August 18th 2018, 11:08pm |
 |
@WatchlistN -$1.16 EPS Expected for Five Prime Therapeutics Inc $FPRX This Quarter https://t.co/j7x9rfvkHP August 18th 2018, 11:08pm |
|
@MareaInformativ Zacks: Analysts Anticipate Five Prime Therapeutics Inc $FPRX Will Post Earnings of -$1.31 Per Share https://t.co/3HeOPbmjdO August 18th 2018, 4:08pm |
|
@TickerReport Five Prime Therapeutics $FPRX Downgraded by BidaskClub https://t.co/TvRzLvO1g5 August 18th 2018, 11:08am |
 |
@dailypoliticaln Five Prime Therapeutics $FPRX Downgraded to “Sell” at BidaskClub https://t.co/d3PYbRUDvT August 18th 2018, 11:08am |
|
@EnterpriseLeade Five Prime Therapeutics $FPRX Price Target Cut to $35.00 https://t.co/u5BYqtZIDJ August 18th 2018, 8:08am |
 |
@1MinuteStock Unicorn Bay rating for $FPRX is 1.69 out of 5. https://t.co/eVCNHf0hLb August 18th 2018, 7:08am |
|
@1MinuteStock Wondering about #sentiment indicator for $FPRX? The Short Ratio is 8.12% https://t.co/0mPOVO3pb3 August 18th 2018, 6:08am |
 |
@TheUnicornBay Btw, Estimated #Earnings Per Share for $FPRX is $-1.31 it's -9.94% of the current price https://t.co/IsGEOR5nmC August 18th 2018, 6:08am |
|
@1MinuteStock Do you know that #Book Value for $FPRX is $10.55 https://t.co/GzXsjhiBfQ August 18th 2018, 5:08am |
|
@1MinuteStock Btw, Estimated #Earnings Per Share for $FPRX is $-1.31 it's -9.94% of the current price https://t.co/DX86jWrkOj August 18th 2018, 4:08am |
|
@MareaInformativ Somewhat Favorable News Coverage Somewhat Unlikely to Impact Five Prime Therapeutics $FPRX Stock Price https://t.co/qmedLOMaIv August 17th 2018, 6:08pm |
 |
@WeekHerald Five Prime Therapeutics $FPRX Downgraded by BidaskClub https://t.co/7nWTZ2DUiG August 17th 2018, 5:08pm |
 |
@OlympiaReport BidaskClub Downgrades Five Prime Therapeutics $FPRX to Sell https://t.co/0LzMubD3XX August 17th 2018, 5:08pm |
|
@Luigimoro69 $FPRX bought another 800shares at 13.48$ now. I think it will double within 12 months. cash ?250m by end of the y… https://t.co/6m8Fyq7qSG August 17th 2018, 10:08am |
 |
@registrarjourn Brokerages Anticipate Five Prime Therapeutics Inc $FPRX Will Announce Earnings of -$1.25 Per Share https://t.co/RVmmZFHII0 August 17th 2018, 2:08am |
 |
@ThisLincolnian Zacks: Brokerages Anticipate Five Prime Therapeutics Inc $FPRX Will Announce Quarterly Sales of $7.45 Million https://t.co/8V1ZHxZQQv August 16th 2018, 4:08pm |
|
@OlympiaReport -$1.16 EPS Expected for Five Prime Therapeutics Inc $FPRX This Quarter https://t.co/ay3N2GhhCn August 16th 2018, 4:08pm |
|
@WeekHerald Analysts Anticipate Five Prime Therapeutics Inc $FPRX Will Announce Quarterly Sales of $7.45 Million https://t.co/AKqtLgxbUH August 16th 2018, 4:08pm |
 |
@dispatchtribune Analysts Anticipate Five Prime Therapeutics Inc $FPRX to Announce -$1.16 Earnings Per Share https://t.co/LhpagBQIpz August 16th 2018, 4:08pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2018. All rights reserved.